Real-life Pan-HER-blockade With Neratinib

CompletedOBSERVATIONAL
Enrollment

304

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

September 5, 2024

Study Completion Date

September 5, 2024

Conditions
Breast Neoplasm
Interventions
DRUG

Neratinib

Neratinib standard dose 240 mg once daily for 1 year

Trial Locations (97)

1003

Clinic, Lausanne

1090

Clinic, Vienna

1140

Clinic, Vienna

2502

Practice, Biel/Bienne

4051

Practice, Basel

4600

Clinic, Olten

4840

Clinic, Vöcklabruck

5020

Clinic, Salzburg

5620

Clinic, Schwarzach im Pongau

7000

Clinic, Chur

8008

Clinic, Zurich

8036

Clinic, Graz

9020

Clinic, Klagenfurt

10367

Medical Practice, Berlin

13156

Clinical Practice, Berlin

14169

Medical Practice, Berlin

14467

Clinic, Potsdam

16816

Clinic, Neuruppin

17489

Medical Practice, Greifswald

18059

Clinic, Rostock

18435

Medical Practice, Stralsund

21339

Clinic, Lüneburg

22307

Oncology Center, Hamburg

23701

Clinic, Eutin

26121

Clinic, Oldenburg

26389

Medical Practice, Wilhelmshaven

26655

Medical Practice, Westerstede

26789

Medical Practice, Leer

28209

Medical Practice, Bremen

28239

Clinic, Bremen

29410

Clinic, Salzwedel

29525

Medical Practice, Uelzen

30625

Clinic, Hanover

31134

Medical Practice, Hildesheim

33332

Medical Practice, Gütersloh

37073

Practice, Göttingen

38642

Community Health Center, Goslar

39108

Clinic, Magdeburg

39288

Medical Practice, Burg

39576

Clinic, Stendal

41462

Community Health Center, Neuss

45138

Clininc, Essen

45468

Medical Practice, Mülheim

45711

Clinic, Datteln

Clinic, Hamm

46236

Medical Practice, Bottrop

47441

Medical Practice, Moers

49124

Medical Care Center, Georgsmarienhütte

50931

Clinic, Cologne

51067

Clinic, Cologne

53123

Medical Practice, Bonn

53840

Medical Practice, Troisdorf

56564

Medical Care center, Neuwied

56727

Medical Practice, Mayen

58452

Clinic, Witten

59494

Community Health Center, Soest

63739

Medical Practice, Aschaffenburg

64283

Clinic, Darmstadt

65189

Clinic, Wiesbaden

65929

Clinic, Frankfurt am Main

67434

Clinic, Neustadt

69115

Medical Practice, Heidelberg

69469

Clinic, Weinheim

71364

Clinic, Winnenden

72622

Clinic, Nürtingen

74523

Clinic, Schwäbisch Hall

76532

Clinic, Baden-Baden

77654

Oncology Center, Offenburg

78052

Medical Practice, Villingen-Schwenningen

79110

Community Health Center, Freiburg im Breisgau

80639

Community Health Center, München

81377

Clinic, München

84034

Clinic, Landshut

84036

Community Health Center, Landshut

84307

Community Health Center, Eggenfelden

86150

Practice, Augsburg

89522

Medical Practice, Heidenheim

91522

Clinic, Ansbach

94469

Clinic, Deggendorf

95615

Clinic, Marktredwitz

96049

Clinic, Bamberg

98527

Clinic, Suhl

Medical Practice, Suhl

98617

Medical Practice, Meiningen

98646

Medical Practice, Hildburghausen

98724

Oncology Center, Neuhaus am Rennweg

99084

Medical Practice, Erfurt

04924

Medical Practice, Bad Liebenwerda

09116

Clinic, Chemnitz

01127

Oncology Center, Dresden

01705

Medical Praxis, Freital

04129

Clinic, Leipzig

08525

Medical Practice, Plauen

06110

Medical Practice, Halle

06484

Clinic, Quedlinburg

07747

Clinic, Jena

07318

Medical Care Center, Saalfeld

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

iOMEDICO AG

INDUSTRY

collaborator

Pierre Fabre Pharma Austria

UNKNOWN

collaborator

Pierre Fabre Pharma AG

INDUSTRY

lead

Pierre Fabre Pharma GmbH

INDUSTRY

NCT04388384 - Real-life Pan-HER-blockade With Neratinib | Biotech Hunter | Biotech Hunter